Panbela Presents Clinical Data on Phase 1b Clinical Trial of SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic PDA at 2021 ASCO Annual Meeting
June 04, 2021 09:15 ET
|
Panbela Therapeutics, Inc.
MINNEAPOLIS, June 04, 2021 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients...
CurrencyWorks to Present at the LD Micro Invitational XI Virtual Event
June 04, 2021 09:15 ET
|
CurrencyWorks Inc
Cameron Chell, Chairman Presenting on June 10th at 900AM PST/1200PM EST Los Angeles CA, June 04, 2021 (GLOBE NEWSWIRE) -- CurrencyWorks Inc. (“CurrencyWorks” or the “Company”), (CSE: CWRK...
Blink Charging To Present at Bank of America’s Electric Vehicles Charging Summit 2021
June 04, 2021 09:15 ET
|
Blink Charging Co.
Miami Beach, FL, June 04, 2021 (GLOBE NEWSWIRE) -- Blink Charging Co. (Nasdaq: BLNK, BLNKW) ("Blink" or the "Company"), a leading owner, operator, and provider of electric vehicle (EV) charging...
Aerpio Provides Second Update on Aadi Bioscience Presentation at the ASCO 2021 Virtual Meeting
June 04, 2021 09:15 ET
|
Aerpio Pharmaceuticals, Inc.
CINCINNATI, June 04, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO) announced that Aadi Bioscience, Inc. (“Aadi”), a privately-held biopharmaceutical company...
Major shareholder notification – BlackRock, Inc.
June 04, 2021 09:14 ET
|
GN Store Nord A/S
GN Store Nord A/S hereby announces that on June 4, 2021, pursuant to Section 38(1) of the Danish Capital Markets Act, it received a notification from BlackRock, Inc. stating that on June 3, 2021...
DRAFTS OF RESOLUTIONS for JSC “Olainfarm” Extraordinary General Meeting of Shareholders on June 18, 2021
June 04, 2021 09:11 ET
|
Olainfarm
DRAFTS OF RESOLUTIONSfor JSC “Olainfarm” Extraordinary General Meeting of Shareholders on June 18, 2021 3. Reports of the Management Board, Council and conclusion of certified auditor Draft...
Europe Microplate Reader Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type, Application, and End User
June 04, 2021 09:10 ET
|
ReportLinker
New York, June 04, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Europe Microplate Reader Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type,...
Aadi Bioscience Presents Emerging Data for FYARRO™ in Patients with Solid Tumors Harboring TSC1 or TSC2 Inactivating Alterations from a Multi-Institution Expanded Access Program at ASCO 2021
June 04, 2021 09:10 ET
|
Aadi Bioscience
Five of six mTOR inhibitor-naïve patients with TSC1 or TSC2 inactivating alterations achieved confirmed partial responses to single-agent FYARROTumor-agnostic registrational trial of FYARRO in mTOR...
Agenus’ Presentations at ASCO 2021 Demonstrate Differentiated Activity of Balstilimab and Provide Clinical Update on AGEN2373
June 04, 2021 09:09 ET
|
Agenus Inc.
LEXINGTON, Mass., June 04, 2021 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines...
Iovance Biotherapeutics Announces Clinical Data for Lifileucel in Combination with Pembrolizumab in Advanced Melanoma at ASCO 2021 Annual Meeting
June 04, 2021 09:08 ET
|
Iovance Biotherapeutics, Inc.
86% Overall Response Rate (ORR) and 43% Complete Response Rate in Immune Checkpoint Inhibitor (ICI) Naïve Advanced Melanoma Patients in IOV-COM-202 Clinical Study Initial 7 Patients Show 3 Complete...